Abstract
Angiogenesis is the process of formation of new capillaries from preexisting blood vessels. Angiogenesis is involved in normal physiological processes, and plays an important role in tumor invasion and development of metastases. Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis. VEGF is a mitogen for vascular endothelial cells and stimulates their proliferation. By inhibiting the biological activity of VEGF, and then signal cascades with neutralizing VEGF antibodies and signal inhibitors, may negatively regulate the growth and metastasis. Anti-angiogenesis therapy is less toxic than chemotherapy. Angiogenesis is a multistep and multifactorial process, and therefore, can be blocked at different levels. In this review article, the authors present the synthesis of novel inhibitors of angiogenesis, together with the results of biological tests in vitro, and in some cases, state trials.
Citations
-
8
CrossRef
-
0
Web of Science
-
1 1
Scopus
Authors (4)
Cite as
Full text
full text is not available in portal
Keywords
Details
- Category:
- Articles
- Type:
- artykuł w czasopiśmie wyróżnionym w JCR
- Published in:
-
CURRENT MEDICINAL CHEMISTRY
no. 22,
pages 3830 - 3847,
ISSN: 0929-8673 - Language:
- English
- Publication year:
- 2015
- Bibliographic description:
- Gensicka M., Siebert A., Dzierzbicka K., Cholewiński G.: Inhibitors of angiogenesis in cancer therapy – synthesis and biological activity // CURRENT MEDICINAL CHEMISTRY. -Vol. 22, nr. 33 (2015), s.3830-3847
- DOI:
- Digital Object Identifier (open in new tab) 10.2174/0929867322666150904111442
- Verified by:
- Gdańsk University of Technology
seen 146 times
Recommended for you
Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis
- M. Świtalska,
- B. Filip‐Psurska,
- M. Milczarek
- + 8 authors
HDAC Inhibitors: Innovative Strategies for Their Design and Applications
- M. Daśko,
- B. De Pascual-Teresa,
- I. Ortín
- + 1 authors